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Abstract: Chronic wounds affect millions of people worldwide. In the UK alone, the cost of their 
treatment is estimated to be between £4.5bn and £5.1bn. The implementation of wound bed 
preparation strategies remove the barriers to healing and wound debridement is a key component in 
preparing the wound bed for wound progression. This article aims to review one of the several 
debridement methods available to clinicians, autolytic debridement. Autolysis (i.e., autolytic 
debridement) uses the body’s own enzymatic mechanisms – used in normal biological processes 
including acute wound healing – enables removal of devitalised tissue in order to remove the 
barriers to healing . This review is aimed to provide clinicians working in wound care a better 
understanding of the mechanisms and implications of autolytic debridement. 
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Key phrases: 
 Devitalised tissue such as slough, eschar and necrotic tissue impedes wound healing 
 Removal of devitalised tissue and wound bed preparation is imperative for wound healing to 
proceed 
 Autolytic debridement is nature’s way of harmlessly and painlessly removing devitalised 
tissue and allowing healing 
 Hydro-Responsive Wound Dressings enable autolytic debridement in chronic and acute 
wounds 
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Introduction 
Chronic wounds affect millions of people worldwide and it is predicted that the prevalence and 
incidence of these wounds will expand due to an aging population with increasing comorbidities 
(Sen et al, 2009; Vowden and Vowden, 2016). A study in 2009 estimated that the cost of managing 
chronic wounds to the NHS was between £2.5bn and £3.1bn per annum (3-4% of the healthcare 
budget) (Posnet et al, 2009). A more recent analysis of wound care costs in the NHS (2012/2013) 
estimated that the cost of wound care and the associated comorbidities for both acute and chronic 
wounds was between £4.5bn and £5.1bn (Guest et al, 2015). In the United States, there is estimated 
to be an excess of $25bn spent annually on the treatment of chronic wounds (Sen et al, 2009). In 
order to help address the growing problem, much work has been done to help better understand 
and improve the clinical management of these wounds. Wound bed preparation has been identified 
as a key to maximising the opportunity for the treatment of chronic wounds, with wound 
debridement being an important aspect in wound bed preparation (Leaper et al, 2012; Sibbald et al, 
2011). 
With the development of the concept of wound bed preparation in order to determine the overall 
status of the wound and to identify ways in which to optimise both the endogenous healing process 
and the effectiveness of therapies, the TIME framework (Tissue, Inflammation/infection, Moisture 
balance and Edge of wound) for wound bed preparation was developed and continually built upon 
to deliver effective chronic wound management (Leaper et al, 2012; Sibbald et al, 2011). 
What is debridement and what is it for? 
There are many definitions of debridement, including “the process in which all materials 
incompatible with healing are removed from a wound” (Cornell et al., 2010, p31S). A more detailed 
definition highlights the importance of wound debridement for preparing the wound bed for 
healing: “the act of removing necrotic material, eschar, devitalised tissue, serocrusts, infected tissue, 
hyperkeratosis, slough, pus, haematomas, foreign bodies, debris, bone fragments or any other type 
of bioburden from a wound with the objective to promote wound healing” (Strohal et al., 2013). 
Debridement is an essential component of wound bed preparation and plays an important role in all 
four of the main stages of the TIME framework (McCallon et al, 2015). Traditionally, the term 
debridement has been used to describe the removal of devitalised tissue from a wound, or more 
generally, the removal of damaged and infected tissue (Vowden and Vowden, 2011). Falanga has 
proposed that the term ‘debridement’ can be divided into two separate parts reflecting to  two 
distinct treatment approaches: the initial debridement following the initial wound assessment and 
maintenance debridement for the ongoing requirement to intervene in order to remove non-viable 
tissue and maintain an optimal wound bed (Falanga et al, 2008). 
For clinicians, debridement can be achieved in a number of ways depending upon what is most 
appropriate for a given patient (Vowden and Vowden, 2011; Leak, 2012; Gray et al, 2011). This 
article will focus on autolytic debridement, other types of debridement include sharp, surgical, 
biologic, mechanical and enzymatic debridement (Table 1). The choice of the optimal debridement 
method will depend on a number of factors including wound characteristics, patient comorbidities 
and clinical history, pain threshold, the availability of clinical resources, and the skills of the wound 
care givers (Vowden and Vowden, 2011; Gray et al, 2011). Also, some procedures are not used or are 
unavailable in the UK (e.g., wet-to-dry dressings, enzymatic) and are highlighted where appropriate. 
 TABLE 1: METHODS OF DEBRIDEMENT* 
METHOD DESCRIPTION ADVANTAGES DISADVANTAGES 
Surgical Removal of non-viable 
tissue with instruments in 
operating theatre 
 Usually removes necrosis at one 
time 
 Fast method 
 Pain-free 
 Selective removal of tissue 
 Takes time to organise 
 Expensive 
 Limited availability and 
level of skill 
 Risks associated with 
surgery 
 If incorrectly performed 
viable tissue can be 
damaged 
Sharp Removal of non-viable 
tissue with instruments 
 Selective removal of tissue 
 Relatively fast method 
 If incorrectly performed 
viable tissue can be 
damaged 
 Repeated procedures may 
be needed if not all 
necrosis removed 
 Not suitable for some 
patients (e.g., on 
anticoagulants). 
Biological Use of maggots applied 
directly to wound 
 Specifically removes only 
devitalised tissue, i.e., selective 
 Has anti-microbial action 
 Relatively fast method 
 Some patients and 
clinicians reluctant to use 
(“Yuck” factor) 
Mechanical Use of dressings to remove 
necrotic tissue during 
dressing removal (e.g., wet-
to-dry dressings (not UK), 
monofilament fibre pad  
 Removes soft eschar 
 Should be pain free 
 Non-selective; removal of 
dressing removes 
viable/healing as well as 
devitalised tissue (wet-to-
dry dressing) 
 Risk of spread of 
debris/bacteria (e.g., 
aerosolisation, splashback 
of tissues/fluids) 
 Relatively slow method 
 Can be painful 
Ultrasound Use of sound waves to 
physically disrupt 
devitalised tissue 
 Fast method 
 Removes devitalised tissue 
 Suited for most types of 
devitalised tissue 
 Risk of spread of 
debris/bacteria (e.g., 
aerosolisation, splashback) 
 Specialised equipment 
required 
 Cost 
 
Hydrosurgery Use of high energy fluid  
stream (saline) to remove 
devitalised tissue 
 Fast method 
 Removed devitalised tissue 
 Suited for most types of 
devitalised tissue 
 Risk of spread of 
debris/bacteria (e.g., 
aerosolisation, splashback) 
 Specialised equipment 
required 
 Cost 
Enzymatic Use of enzymes that 
degrade components of 
tissue (e.g., extracellular 
matrix) (not available in UK) 
 Can be applied directly to wound 
 Easy method to use 
 Should be pain free 
 Can cause peri-wound 
tissue damage (i.e., non-
selective) 
 Possible hypersensitivity 
to some enzymes in some 
patients 
 Relatively slow method 
Autolysis Promotion of a balanced 
hydration environment at 
wound site  
 Can be applied directly to wound 
 Easy method to use 
 Does not harm viable tissue, i.e., 
selective 
 Should be pain free 
 May cause reversible 
hyper-hydration 
 May cause maceration if 
not appropriately applied 
 Relatively slow method 
*Modified from Davies (2004), McCallon et al (2015) and Gray et al (2011) 
Generally, the various methods of debridement can be placed into two broad categories: non-
selective and selective debridement. With non-selective debridement methods (e.g., mechanical 
(i.e., wet-to-dry dressings), aggressive surgical or sharp debridement), surrounding viable tissue may 
be removed along with the removal of devitalised tissue particularly if the devitalised tissue is tightly 
associated with the underlying viable tissue (e.g., wet-to-dry dressing mechanical debridement). 
Viable or healing tissue adjacent to a region of devitalised tissue may be damaged (leading to 
bleeding) as a result of the uncertainty in assessing the boundary between devitalised and viable 
tissue in cases of aggressive surgical or sharp debridement (Albaugh and Loehne, 2010; Gray et al, 
2011). The insensate and avascular nature of devitalised tissue means that the removal of this tissue 
should be painless and without bleeding. However, the sensation of pain and bleeding results when 
adjacent viable tissue is damaged (Cornell et al, 2010) and is dependent upon the skill and extent of 
the debridement by these methods. Selective debridement methods offer targeted removal of 
devitalised tissues and minimising peri-wound tissue damage. Appropriate surgical and sharp 
debridement procedures can result in the removal of only devitalised tissue though this is very much 
dependent upon the skill of the practitioner applying surgical/sharp debridement (though 
devitalised tissue may remain in the wound in an effort to protect the surrounding viable tissue). 
Biological and autolytic debridement relies on the harnessing of tightly controlled enzymatic 
processes of biological systems. Larval therapy (i.e., biological debridement)  the removal of necrotic 
and devitalised tissue via the partial liquefaction of dead tissue by enzymes secreted by the larvae. 
On the other hand however autolytic debridement uses the body’s own enzymes that are produced 
as part of normal biological processes such as inflammation to digest dead tissue. The presence of a 
moist environment is required for the digestion of devitalised tissue to progress efficiently (Gray et 
al, 2011; Meaume et al, 2012). 
The removal of devitalised tissue from the wound is thought to be a necessary step for wound 
progression to occur (Ayello and Cuddigan, 2004; James et al, 2008). Although only one of a number 
of potential processes that can act as a barrier to healing, the presence of necrosis and devitalised 
tissue in the wound is particularly important in that it forms a physical barrier to the formation of 
new tissue (Gray et al, 2011). Wound debridement results in the removal of these physical 
obstructions and allowing the processes important for healing to continue (Ayello et al, 2006; Weir 
et al, 2007). The removal of devitalised tissue and the establishment of a viable wound bed also 
allows for the optimised treatment of chronic wounds (Panuncialman and Falanga, 2009; Halim et al, 
2012). In a small study in 143 patients with diabetic foot ulcers (DFUs), Saap and colleagues assessed 
the validity of a Debridement Performance Index (DPI), a scoring system to assess the quality of 
wound debridement (Saap and Falanga, 2002). They found that there was a correlation between the 
DPI and the incidence of DFU closure: the lower the DPI the lower the incidence of wound closure by 
week 12. This study suggests that effective and timely debridement of chronic wounds may support 
optimised healing. The authors of this study suggest that DPI may be a useful predictive tool for 
determining the outcome of clinical trials. 
Debridement is thought to be necessary in order to help transform the chronic wound environment 
back to an acute wound (Panuncialman and Falanga, 2009; McCallon et al, 2015). That is, the 
removal of devitalised tissue with each repeated debridement helps reduce or negate the effects of 
chronicity by removing the local wound factors that contribute to maintaining the chronic wound 
(e.g., devitalised tissue, biofilm). With the removal of these factors, the wound healing  process is 
normalised (Falanga, 2004; Ramundo and Gray, 2008) and wound progression can occur. 
The removal of devitalised tissue allows clinicians to fully assess wounds (Weir et al, 2007) and to 
remove factors that impair wound healing and may not be clinically detectable during clinical 
evaluation (Leaper et al, 2012; Falanga et al, 2008). These may include a high bacterial burden 
(planktonic bacteria or biofilm) which may result in increased risk of infection (O’Brien et al., 2002; 
Kammerlander et al, 2005), and elevated tissue proteinases. 
What is ‘devitalised tissue’? 
Although clinical observations describe several types of devitalised tissue (Table 2), there has been 
little research on the physical, chemical and biological characterisation of this dead tissue  
`  
Figure 1: A diabetic foot wound showing necrosis and 
slough 
  
 
Figure 2: A heel ulcer showing eschar 
(Percival and Suleman, 2015). It is clear, however, that there can be significant variability in the 
properties of non-viable tissues between patients (European Wound Management Association, 
2004). However, despite this variability, general characteristics of necrotic tissue and slough have 
recently been proposed (Percival and Suleman, 2015). Necrotic tissue is a hard, dry tissue that is 
generally black/brown in colour and is firmly attached to the underlying viable tissue (Figure 1). 
Although considered to be a separate phenomenon (Grey et al, 2006), clinical experience suggests 
that wound eschar (Figure 2) does have a number of similar characteristics to necrotic tissue. Table 2 
itemises the similarities and differences between the three main types of devitalised tissue. Dry, 
black and hard necrotic tissue, eschar and necrotic tissue appears to be made up of a fibrous mass of 
extracellular matrix components (e.g., fibronectin, collagen, elastin fibres) (Percival and Suleman, 
2015; Thomas et al, 1999), dried skin and granulation tissue (Black et al, 2010). 
TABLE 2: CHARACTERISTICS OF DEVITALISED TISSUE* 
Characteristics Necrotic tissue Slough Eschar 
Black/dark brown Generally Not generally Generally 
Loosely attached No Yes – generally No 
Very firmly attached Yes No – not generally Yes – generally 
Dead cells Yes Yes Yes 
Fibrin Yes – low level Yes – high level Yes – low level 
Biofilm Yes Yes Yes 
Microorganisms Yes Yes Yes 
White blood cells No Yes Yes 
‘Houses exudate’ No Yes No 
Viscoelastic No Yes No 
*Modified from Percival & Suleman (2015) 
Wound slough is very different from necrotic tissue/eschar. It is generally pale yellow or 
yellow/brown in colour (Figure 3). It is a soft tissue and is generally more loosely attached to the 
underlying tissue when compared with the strength of attachment of necrotic tissue (Percival and 
Suleman, 2015). Slough is composed of white blood cells, bacteria and foreign material, and dead 
tissue. It contains a mixture of serum proteins (fibrin, albumin, immunoglobulins), denatured 
extracellular matrix proteins and is thought to be a by-product of the immune-related clearance of 
cellular components during the healing response (Brown, 2013; Percival and Suleman, 2015). Slough 
is thought to be the result of the heightened inflammatory state found in the chronic wound. 
Common to all the devitalised tissues, these dead tissues are thought to be an environment where 
biofilms are able to form and thrive (Percival and Suleman, 2015). 
Autolytic debridement 
There are a number of debridement techniques available to clinicians (Table 1). Autolytic 
debridement (‘autolytic’ derived from the Greek words meaning ‘self’ and ‘splitting’) is a process 
that takes place in wounds and is responsible for the breakdown of tissue damaged during wounding 
and the scab formed over an acute wound. In chronic wounds, autolytic debridement uses the 
body’s own enzymes and moisture to rehydrate, soften and partially-digest devitalised tissue (Gray 
et al, 2011). The establishment of an optimal level of hydration is important as these enzymes 
require optimised moisture levels to deliver their full level of activity (Rezaei et al, 2007). The use of 
moist wound-management protocols and moisture-donating and/or moisture-retentive dressings 
(Table 3) to establish and maintain a moist wound healing environment optimises the enzymes 
required for autolysis (autolytic debridement). Several types of enzymes (e.g., elastases, 
collagenases (Matric Metallo-Proteases MMPs), myeloperoxidase, acid hydrolases and lysosomal 
enzymes) then begin the process of autolysis (Ramundo and Gray, 2009; Enoch and Harding, 2003; 
Singhal et al., 2001). Proteolysis – the breakdown of proteins by the action of enzymes (proteolytic 
enzymes) – is largely responsible for the breakdown of the protein components of the devitalised 
tissue. The initial breakdown of this devitalised tissue then allows further digestion of the tissue by 
specialised inflammatory cells (macrophages) (Diegelmann and Evans, 2004). The detachment of 
devitalised tissue is facilitated by the action of these proteolytic enzymes. It has been suggested that 
the breakdown and removal of cellular debris assists in maintaining the process of autolytic 
debridement (Hermans and Cutting, 2013). 
Figure 3: A leg ulcer showing slough within wound 
bed 
Promotion of autolytic debridement by wound dressings 
Wounds dressings that promote a moist wound environment encourage autolytic debridement. 
There is no prescribing time limit for leaving these dressings in place, this will be determined 
through individual assessment of each patient and will be dependent upon manufacturer’s 
instructions, levels of exudate, patients general condition and any underlying comorbidities. Each 
wound assessment should be clearly documented in the patients’ notes with dates for future review. 
When the dressing is removed, the liquefied tissue can be removed with the dressing and the wound 
can be irrigated in order to wash out any remaining tissue.  
Due to the selective nature of autolytic debridement (Schultz et al, 2003; Strohal et al, 2013), this 
method is less stressful for patients compared with other debridement methods as it causes little or 
no pain. It is also considered to be the safest method of debridement available because of its 
property of only removing devitalised tissue (Gwynne and Newton, 2006). However, debridement 
can take longer than other methods, requiring multiple dressing applications and can take several 
weeks depending upon the extent of necrosis/slough (Davies, 2004; Mosher et al, 1999; Davies et al, 
2005). Because autolytic debridement requires endogenous protein-degrading enzymes – many of 
them from inflammatory cells – for effective removal of devitalised tissue, patients with impaired 
immune and inflammatory responses (due to medications or disease) may not show an effective 
autolytic response (McCallon et al, 2015). 
As well as the promotion of autolytic debridement processes by the establishment of a moist wound 
environment, the dressing’s ability to remove wound exudate and devitalised tissues during dressing 
changes probably increases the activity of autolysis. The removal of devitalised tissue – the target of 
the enzymes responsible for tissue digestion – allows for the limited levels of autolytic debridement 
enzymes present in the wound environment to digest devitalised tissues remaining at the wound 
site rather than digesting debris already digested. 
These dressings capable of promoting autolytic debridement can generally be divided into two 
categories: those that donate moisture to the dry devitalised tissue and those that absorb excess 
moisture (wound exudate) produced by the tissues (Hofman, 2007) (Table 3). Hydrogels (gels and 
sheets) donate moisture to the dead tissue because of the high moisture content of the dressing. 
Hydrocolloids, alginates, cellulose and foam dressings are designed to absorb exudate from the 
wound creating a moist interface between the dressing and the wound surface and promoting a 
moist environment and hydration of the dry devitalised tissue. It should be noted that hydrocolloids 
also have absorption capacity and can generate moisture through their semi-occlusive nature and 
gel-forming property when in contact with exudate. This facilitates autolytic debridement (Ousey et 
al, 2012). 
Recently, a third category of wound dressing has been developed that encourages autolytic 
debridement: hydro-responsive dressings. These dressings can deliver and absorb moisture 
depending on the environmental fluid balance, providing hydration to soften and detach devitalised 
tissues such as necrosis and slough and absorbing bacteria- and proteinase-laden exudate into its 
absorbent core (Ousey et al, 2016).  
TABLE 3: MECHANISM OF OPTIMAL HYDRATION FUNCTION 
Dressing Class Fluid Retention/Donation 
Alginates Retention 
Foams Retention 
High-absorption dressings Retention 
Hydrofiber Retention 
Hydrocolloids Retention 
Hydrogels Donation 
Hydro-Responsive Wound Dressings (HRWDs) Retention & donation 
 
Low to moderate quality evidence supporting the benefits of a number of debridement methods, 
including autolytic debridement, in the treatment of diabetic foot ulcers (DFUs) has been reported. 
Two RCTs suggest autolytic debridement of DFUs is associated with a statistically significant increase 
in healing rates compared with standard wound debridement by gauze and conventional wound 
care (Elraiyah et al, 2016). A review of the impact of wound debridement in wound healing in leg 
ulcers noted some evidence for the benefit of autolytic debridement (Doerler et al, 2012). In a 
prospective, RCT in 42 patients with leg ulcers treated with either a hydro-responsive wound 
dressing (HRWD) or an enzymatic debridement preparation, the HRWD group showed a reduction in 
devitalised tissue of approximately 19% (versus 9% in the enzymatic preparation group) and an 
increase in granulation tissue (26% vs. 10%) during days 1-14 (König et al, 2005). AIthough enzymatic 
debridement is not routinely used in the UK and the study was not statistically significant it does 
identify the potential benefits of using HRWD as a debridement technique. 
 
Figure 4: Autolytic debridement of necrosis and slough by HRWD dressing in a diabetic foot ulcer shown in Figure 1 
Meaume (2012) used a cohesive, autolytic wound dressing featuring ‘hydro-desloughing fibres’ in a 
pilot, prospective, non-controlled open-label study evaluating desloughing in venous leg ulcers 
(n=35) and pressure ulcers (n=15). All patients had wounds >50% covered with sloughy material. 
Patients were followed over a 6-week period. All wounds were considered debrided (<40% slough) 
by week 3 with a median relative decrease of sloughy tissue of 75% and 89% of venous leg ulcers 
and pressure ulcers respectively. In a recent multicentre RCT on patients with sloughy venous or 
mixed aetiology leg ulcers, 159 patients were treated with one of 2 fibrous wound dressings and 
followed over a 6-week period with the relative level of sloughy tissue being assessed (Meaume et 
al, 2014). Both autolytic dressings resulted in a relative reduction of sloughy tissue and an increase in 
the percentage of debrided wounds at the end of the observation period. It should be noted that a 
total of 25 patients withdrew from the study, and that a total of 16 local adverse events considered 
to be potentially related to the study dressings were reported (in 15 patients). 
In a recent multicentre, open, prospective, randomised and two-arm parallel study group study, 
Humbert et al (2014) reported on a 75-patient study to assess the autolytic debridement properties 
of a hydro-responsive wound dressing on wound bed preparation in venous leg ulcers. After 14 days, 
there was a reduction in fibrinous and necrotic tissue of 37.6% in the HRWD group compared with a 
reduction of 16.8% in a comparative group treated with an amorphous gel. There was a 
corresponding increase in the proportion of ulcer area covered by granulation tissue. A report of a 
20-patient community-set evaluation study demonstrated HRWD promoting wound bed progression 
and wound healing in patients with chronic wounds (Spruce et al, 2016). There was a mean 
reduction of 62% in the level of devitalised tissue in these wounds. 
Conclusion 
The increasing prevalence and negative socioeconomic effects of chronic wounds have made the 
need for better, more cost-effective therapies for these wounds. Wound bed preparation has been 
identified as being important to delivering effective wound care for these wounds with debridement 
being a key component as the removal of devitalised tissues displaces many of the barriers to 
healing.  The choice of debridement method is dependent upon a number of patient- and clinician-
related factors. Autolytic debridement is a selective process for removing devitalised tissue, relying 
on the tissue’s own enzymes to soften and detach areas of necrosis and slough. The establishment 
of balanced hydration levels in the wound with the promotion of a moist environment with 
advanced wound care products maximises the autolytic potential of chronic wounds. Wound 
dressings that promote a moist environment through the retention of excess wound fluid (e.g., 
alginates) or the donation of fluid locked within the dressing (e.g., hydrogels), or innovative 
dressings, such as HRWDs, that are able to both retain and donate fluid offer the opportunity for 
autolysis to promote the selective removal of devitalised tissue. 
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